chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headaches; Right deltoid is very tender to touch at injection site; A little weak feeling running to right shoulder blade; This is a spontaneous report from a contactable pharmacist reporting for himself. A 51-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL1284), intramuscular (right arm) on 08Jan2021 07:15 at SINGLE DOSE for COVID-19 immunization. The patient's other medical history was not reported. The vaccine was given at hospital. No other vaccines in four weeks. Patient did not have COVID-19 prior vaccination and was not tested for COVID-19 after vaccination. Patient has no known allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot: EJ1685) on 21Dec2020 07:15, left arm at single dose and experienced headaches, general malaise, moderate soreness at left deltoid running down thru left shoulder and mid back on 21Dec2020 18:00, with no treatment given. Concomitant medication included krill oil and an unspecified multivitamin; unspecified dates and indication. On the second vaccine, patient experienced same headaches starting the evening of after getting second vaccine on 08Jan2021. Patient also experienced headaches feel exactly the same as before, seemingly in the middle, top half of head, right deltoid is very tender to touch at injection site, and a little weak feeling running to right shoulder blade all on unspecified date in Jan2021. No treatment was given. Outcome of the events was unknown. The reporter assessed the events as non-serious.
Patient experienced headache, nausea, vomiting and blurred vision. Patient went to ER on 02/25/2022 for evaluation.
Fever started Saturday 5/23/09 102.2- gave MOTRIN and TYLENOL to help bring fever down. Rash started on Sunday-was flat and then red pimple or dots. To doctor today 5/26/09, a few spots are fluid filled. Has cough, sniffles. Still has rash now.
infection in my gums; broke my tooth; This is a spontaneous report from a non-contactable Other healthcare professional (HCP) who reported for herself. This other HCP reported events after first and second dose of the vaccine. This case is for events after the first dose. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported) on an unspecified date at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient stated she had the first dose of the vaccine and later (date unspecified) she broke her tooth and the dentist put her on the antibiotic because they saw she had an infection in her gums. The outcome of the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021188750 same patient, same drug(different dose) and different event
Was coughing , had chills back pain, fever,  Stayed home wed, Thursday.  Went back to wk Friday.  Sat at work she couldn't taste or smelled food.  Took covid test, +for covid on 1/2/21. On 1/13/21 had another covid test it was negative. Congestion, h/a cough.  Feels better and report back to work 1/18/21.
Again, approximately 12 hours after injection- nausea, dizziness, slight fever, overall aches, headache
Patient received doses from two different manufactures / first dose 04May2021 which was a Moderna / on 27July2021 and received a dose of Pfizer; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Aug-2021 and was forwarded to Moderna on 17-Aug-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received doses from two different manufactures / first dose 04May2021 which was a Moderna / on 27July2021 and received a dose of Pfizer) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 04-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received doses from two different manufactures / first dose 04May2021 which was a Moderna / on 27July2021 and received a dose of Pfizer). On 04-May-2021, INTERCHANGE OF VACCINE PRODUCTS (Patient received doses from two different manufactures / first dose 04May2021 which was a Moderna / on 27July2021 and received a dose of Pfizer) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medications were reported.
Information has been received from a registered pharmacist concerning a 65-year-old female with codeine, beta blockers, iodine and a sulfa allergy who on 02-NOV-2007 was vaccinated subcutaneous in the left arm with 0.65 ml dose of ZOSTAVAX (658602/1080U). Concomitant therapy included oxybenzone. On 04-NOV-2007 the patient experienced a red, warm, slightly inflamed rash at the site of administration. The patient sought medical attention via a conversation with the pharmacist. At the time of the report patient's status was not recovered. A product quality complaint was not involved. Additional has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (Difficulty swallowing, difficulty drinking), CHEST DISCOMFORT (Tightness in chest when he swallows), PRODUCTIVE COUGH (Phlegm building up in his mouth, phlegm created from his mouth over night), FEEDING DISORDER (Difficulty eating) and RASH PRURITIC (Wherever he itches it would turn into a rash) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 064421A, 040B21A and 005221A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, the patient experienced DYSPHAGIA (Difficulty swallowing, difficulty drinking), CHEST DISCOMFORT (Tightness in chest when he swallows), PRODUCTIVE COUGH (Phlegm building up in his mouth, phlegm created from his mouth over night), FEEDING DISORDER (Difficulty eating), PYREXIA (Fever, overheating) and CHILLS (Chills). On 24-Nov-2021, the patient experienced RASH PRURITIC (Wherever he itches it would turn into a rash), URTICARIA (Hives around his body, wherever he itches it would turn into a hive), MYALGIA (Aching muscles) and HEADACHE (He also had a pretty bad headache). At the time of the report, DYSPHAGIA (Difficulty swallowing, difficulty drinking), CHEST DISCOMFORT (Tightness in chest when he swallows), PRODUCTIVE COUGH (Phlegm building up in his mouth, phlegm created from his mouth over night), FEEDING DISORDER (Difficulty eating), RASH PRURITIC (Wherever he itches it would turn into a rash), URTICARIA (Hives around his body, wherever he itches it would turn into a hive), PYREXIA (Fever, overheating), CHILLS (Chills), MYALGIA (Aching muscles) and HEADACHE (He also had a pretty bad headache) outcome was unknown. Treatment information was not provided.
About ten minutes after administration I began to feel prickly, burning on my arms which gradually got worse over the next 20 minutes and spread to my hands, sides, back and legs.  Arms were very red. Informed clinic medical provider who took vitals. blood pressure was 186/116 o2 sat were normal.  was given an im shot of benedryl and water, vitals were continued to be monitored and blood pressure came down to 145/84.  Prickly burning sensation and redness continued. Went home and examined body and did have several hives on back and upper arm. slept due to benedryl, woke up to a very sore arm, achy joints but the prickly burning had mostly resolved. next day still feel tired and achy in joints but burning is gone.
Sore arm; Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication and treatment information was not provided.
Redness, warm, pain, swelling above elbow. No prior reaction to DTaP. Examined by provider 5/22/02. Put on Tylenol after vaccine.
This non-serious spontaneous case, initially received from other non-health professional on 13-Nov-2018, concerns a 72-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius (explicitly coded as incorrect product storage). On 15-Oct-2018, the patient was administered FLUAD (TIV) [batch number: 250795, dose, route of administration, anatomical location and expiry date: not reported] which underwent temperature excursion (explicitly coded as drug administration error). At the time of this report, no adverse event was reported. This case 201805522 was crossed linked to original cases 201804863 due to same reporter.
pt recv vax & w/in 5min of vax & passed out for several seconds;pt was observed for 30min & sent home;
Diagnosis of Shingle. Came on slow but continued to get worse over the course of one month.
This spontaneous report as received from a registered pharmacist refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 16-MAY-2017, the patient was vaccinated with an expired dose of PNEUMOVAX 23 injection (lot# L029073, expiry date 19-APR-2017; exact dose and route of administration were not reported). The vaccine was not involved in any temperature excursion. There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
Presented SOB, fever, H/A, loss of taste; Covid + in ED; admite with Covid PNA; tx with Vit C, steroid, supplemental O2
not able to keep anything down; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (not able to keep anything down) and NAUSEA (extreme nausea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION COMPLICATION (not able to keep anything down) and NAUSEA (extreme nausea). The patient was treated with GLUCOSE, POTASSIUM CITRATE, SODIUM CHLORIDE (PEDIALYTE 30) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (not able to keep anything down) and NAUSEA (extreme nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
Was woken up by severe all over body aches and chills. Took temp 101.7. I had extreme fatigue, temp, body aches, and nausea all through the 11th.
4/20/21 shot at 2 p.m.  Injection site pain came on in about 2 hours and stayed for a few days but got better each day.  Chills came on around 6 p.m. (4 hours after the shot) then just a general feeling of malaise.  By morning of 4/21/21 (6 a.m.), joint pain had set in and I felt like I could feel every bone and joint in my body.  I also had chills on and off through the day.  I missed part of work that day while I tried to rest.  Took tylenol as directed at .  That night I had chills again then spiked a fever of 101.8.   Pain subsided the next morning  of 4/22/21 around 10 a.m.
Information has been received from a registered nurse, for VARIVAX (Merck), a Pregnancy Registry product, concerning an 18 year old female patient who was vaccinated with the first dose of VARIVAX (Merck) (lot number unknown) on 11-AUG-2003, and the second 0.5 ml dose (lot number 667922/0758Z) in the right arm on 21-DEC-2010. There was no concomitant medication. On an unknown date after receiving the VARIVAX (Merck) the patient began to vomit. On 27-DEC-2010 the patient went to the doctor and was administered a pregnancy test which came back positive. As of 28-DEC-2010, it was unknown if the patient would continue to receive the VARIVAX (Merck), and the outcome of the vomiting was unknown. Additional information has been requested.
my arm was hurting at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (my arm was hurting at the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder and Diabetic.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PAIN (my arm was hurting at the injection site). At the time of the report, VACCINATION SITE PAIN (my arm was hurting at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medication were reported no treatment medication were reported   This case was linked to MOD-2021-402853, MOD-2021-402823 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Dec-2021: Follow up received contains secondary reporter's information.
Grey skin tone, lethargic, no desire to eat, bloody stool. After sleeping in very late and looking grey, his mother took him to his doctor's office who advised to call with any new symptoms. Imediately following the visit, patient had a bloody stool. Dr. recommended the emergency department at hospital. Patient had an ultra sound and x-ray that confirmed Intussusception. The first treatment was an air enema which was unsuccessful after numerous attempts, he then went into surgery where laproscopic and exploratory surgery was performed by Dr. The exploratory surgery was successful at correcting the prolem. Patient was on morphine and Tylenol for two to three days and allowed to eat gradually 2 days after surgery.
Bells Palsy (loss of taste, dry eye, acute facial paralysis on right side of face)
Patients received an expired dose; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information was reported by reporter.
Shortness of breath and fluttering or pounding heart. Started about 3 weeks after the second dose of mRNA vaccine. The conditions lasted for about 2-3 weeks. Saw a cardiologist towards the end of the symptoms. No significant findings.
Client described next day injection site, redened and swollen.  Slightly itchy.  Seen in Clinic 12/23 Arm at injection site remgins redened to about 4 cms.  Bruised at injection site and edges of redness.
When I had COVID-19, I had a sore throat, headache, phlegm in the throat. I had had surgery on 2/1/2023 to have my breast implants removed. The doctor decided that because of my age, recent surgery, and atrial fibrillation, I was a candidate to take Paxlovid. I began taking Paxlovid on around 2/5/2023. I had abdominal pain, but I don't know if that was caused by the Paxlovid or the COVID-19. I used an online service whose name I don't recall  to receive my prescription. I tested negative for COVID-19 on a home antigen test on about 2/11/2023.
Nauseated, Pasty, eyes unfocused and pale, syncopal episode, Vitals checked after placed in Trendelenberg position, Juice given when more alert.
My left arm became very sore/painful a few hours after the vaccination.  I was not able to raise my arm at the shoulder without experiencing severe pain .  At 4 days later I was able to raise it with mild pain.     My arm was very sensitive to touch, and resting a sheet on it was too painful to leave the sheet on it for 2 days. The arm pain began to fade after 2 days, but 6 days later it still hurts if I press on it.  I was extremely tired for 2 days and slept a lot.  I had a mild headache for 2 days.  I had body aches for 2 days, and I had the chills for 2 days.
Humming in ears; This is a spontaneous report from a contactable nurse. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an intramuscular route of administration on 27Apr2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hyperlipidemia, hypocalcemia, vitamin d deficiency, penicillin allergy, peanut allergy, shellfish allergy, reaction to sulfites and food allergy (chocolate and eggplant allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ubidecarenone (COENZYME Q10), vitamin b12 nos (VITAMIN B12), methylsulfonylmethane (MSM), fish oil/vitamin e nos (OMEGA 3), probiotics nos (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and vitamin k nos (VITAMIN K) all from an unknown date and unknown if ongoing for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0151), via an intramuscular route of administration on 06Apr2021, as a single dose for COVID-19 immunisation. The patient previously took sulfur (MANUFACTURER UNKNOWN), estrogen nos (MANUFACTURER UNKNOWN) and progesterone(MANUFACTURER UNKNOWN) and experienced allergy with all. On 11May2021, the patient experienced humming in ears. Therapeutic measures as a result of the event included treatment with flonase nasal spray and ASA 81mg. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event humming in ears was not resolved at the time of this report.
Patient was given 7+ doses of Fluzone vaccine to the right deltoid.  Supervisor notified at the end of day by administrator. Patient was contacted after consulting with MD . Patient to report any Adverse effects. patient to monitor for fevers and ice injection site if any swelling, and take ibuprofen for pain to injection site. Per MD to report event to VAERS.
Pfizer-BioNTech COVID-19 Vaccine EUA Rec'd Pfizer-BioNTech COVID-19 Vaccine on 2/4/2021 and 2/25/2021. Transferred arrived with worsening hypercalcemia and acute hypoxic resp fail requiring BiPAP. Intubated and NG tube placed. Failed weaning trials. Had an A-fib with RVR event and hypotension. Transitioned to DNR/COT on 7/28. Continued on full vent support and became febrile. Pt expired 8/4/2022. Tx'd w/cefepime, vancomycin, meropenem, metronidazole, and dexamethasone.
2hrs p/vax c/o watery eyes, lump in throat as afternoon progressed, eyes red, throat tight, cont get worst; no prob w/breathing; took DPH & gave some relief;
pt brought to ED (Hospital) via EMS; pt lost consciousness while transferring to bed at home; acute change in mental status; pt with agonal respirations; positive for COVID; intubated then found to be pulseless; CPR but no rhythm ever obtained; pt passed away in the ED; pt received COVID booster vaccine the day before her death.
Left side Swollen Lymph nodes was reported as worsned.; Left Forearm hurting and swelling; forearm hurts super bad; the lymph nodes were really tender, she would push it and it would hurt; lymph nodes on her arms got swollen to softball size/ Left side Swollen Lymph nodes/ the lymph nodes getting bigger; This is a spontaneous report from a contactable consumer reporting for herself. A 26-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on the left arm on 19Jan2021 at a SINGLE DOSE for covid-19 immunisation. Medical history was reported as none. Concomitant medication included etonogestrel (NEXPLANON) for contraceptive implant. The patient received the first dose of BNT162B2 on 29Dec2020. The patient reported a side effect from receiving the vaccine, lymph nodes on her arms got swollen to "softball size" since 19Jan2021 when she received the second dose of the vaccine and wants to know if this was normal. She understands that the arm was going to hurt, but she was noticing that her forearm hurts super bad and it a bit swollen, just on the side of the forearm its swollen, but under that arm her lymph nodes are swollen, she can barely pick up the arm and it just hurts on 20Jan2021. She noticed yesterday (19Jan2021), the lymph nodes were really tender, she would push it and it would hurt. Then when she got home from work, she lifted the arm to look at it, and she could see the swollen lymph nodes, the longer she kept the arm up, she could see the lymph nodes getting bigger. She wants to know how long this will last. She was talking to her mom and she was freaking out saying that people are dying from covid and the swollen lymph nodes, and that's why she has called today. She also stated that her left side swollen lymph nodes was worsened on an unspecified date. The outcome of the event swollen lymph nodes was not recovered, left forearm hurting and swelling and forearm hurts super bad was recovering while other events were unknown.   Information on the Lot/Batch number has been requested.